GlassScriptPhysician profile
Lindsey Knapke
NPI 1447607932
$4,267.24
in general payments reported to CMS, 2019-2025
27 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what 84% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $44.10 · 2021: $224 · 2022: $847 · 2023: $1,049 · 2024: $1,105 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,973 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,972.96 |
| Education | $179.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,075.06 | 2020-2025 | |
| Astellas Pharma US INC | $611.60 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $609.37 | 2021-2025 | |
| Agile Therapeutics, INC. | $338.87 | 2021-2024 | Twirla |
| Optumhealth Care Solutions, LLC | $260.06 | 2023-2025 | Eitan Medical, Vivify Health Care Team Portal 001, Zyno Solutions |
| Biogen, INC. | $220.36 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $191.42 | 2022-2024 | Slynd |
| Organon LLC | $146.19 | 2021-2025 | Nexplanon |
| Exact Sciences Corporation | $102.59 | 2023-2025 | Cologuard Collection Kit |
| Coopersurgical, INC. | $101.01 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Channel Medsystems, INC. | $82.25 | 2022 | |
| Millicent US INC | $76.14 | 2024-2025 | Intrarosa, Femlyv |
| Amgen INC. | $70.84 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $69.85 | 2022-2024 | Gardasil 9, Gardasil |
| Pacira Pharmaceuticals Incorporated | $50.83 | 2023-2024 | Exparel, Iovera, Zilretta |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $39.49 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Shield Therapeutics INC | $29.99 | 2025 | |
| Octapharma USA, INC. | $28.30 | 2025 | Fibryga |
| Mylan Pharmaceuticals INC. | $24.41 | 2021 | |
| Gynesonics, INC. | $21.04 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $19.94 | 2022 | |
| Evofem Biosciences, INC. | $19.59 | 2021 | |
| Baxter Healthcare | $18.06 | 2025 | Perclot |
| Minerva Surgical, INC | $17.61 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.41 | 2023 | |
| Pfizer INC. | $14.22 | 2023 | |
| Aspira Women'S Health INC | $13.74 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Knapke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.